Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-007703
Filing Date
2025-02-25
Accepted
2025-02-25 15:41:04
Documents
3
Period of Report
2025-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740516057.html 4  
1 FORM 4 wk-form4_1740516057.xml 4 5484
2 EX-24 obyrne-form144andsection.htm EX-24 3077
3 obyrne-form144andsection001.jpg GRAPHIC 190392
  Complete submission text file 0001628280-25-007703.txt   272364
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address VIR BIOTECHNOLOGY, INC. 1800 OWENS ST., SUITE 900 SAN FRANCISCO CA 94158
Business Address
O'Byrne Jason (Reporting) CIK: 0001871145 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 25662779